Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge
- 1 October 2011
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 7 (5) , 580-587
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA135011, CA136494, GM GM077173)
This publication has 45 references indexed in Scilit:
- Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancerThe Lancet Oncology, 2010
- A Current Review of Targeted Therapeutics for Ovarian CancerJournal of Oncology, 2010
- Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticlesNature Materials, 2008
- Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cellsJournal of Nanobiotechnology, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Polyphosphate blocks tumour metastasis via anti-angiogenic activityBiochemical Journal, 2007
- Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosisJournal of Nanobiotechnology, 2007
- Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC CellsNano Letters, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Basic fibroblast growth factor is a β-rich proteinThe Protein Journal, 1991